Fritextsökning
Artiklar per år
Innehållstyper
-
Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
New map of eye proteins
A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
View pathology images in your iPhone
The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
SDU professor helps EU
Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Biogaia's advance goes on
In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.
-
New CEO to Swedish Tillotts Pharma
The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.
-
Danish discovery could help cardiac patients
The Danish researchers have developed a component that could make live easier forpatients with heart failure.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
EU grants project on toxicity of nanomaterials
A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on the immune system.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.